Global Virus-like Particle Market Research Report 2024(Status and Outlook)

Global Virus-like Particle Market Research Report 2024(Status and Outlook)



Report Overview:

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.

The Global Virus-like Particle Market Size was estimated at USD 353.72 million in 2023 and is projected to reach USD 586.73 million by 2029, exhibiting a CAGR of 8.80% during the forecast period.

This report provides a deep insight into the global Virus-like Particle market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Virus-like Particle Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Virus-like Particle market in any manner.

Global Virus-like Particle Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

The Native Antigen Company

Creative BioStructure

Creative Biolabs

Leadgene Biomedical

Abcam

ACROBiosystems

Gentarget

VectorBuilder

Market Segmentation (by Type)

E. coli

Yeast

Insect Cells

Others

Market Segmentation (by Application)

Vaccine

Therapeutics

Bioimaging

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Virus-like Particle Market

Overview of the regional outlook of the Virus-like Particle Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Virus-like Particle Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Virus-like Particle
1.2 Key Market Segments
1.2.1 Virus-like Particle Segment by Type
1.2.2 Virus-like Particle Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Virus-like Particle Market Overview
2.1 Global Market Overview
2.1.1 Global Virus-like Particle Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Virus-like Particle Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Virus-like Particle Market Competitive Landscape
3.1 Global Virus-like Particle Sales by Manufacturers (2019-2024)
3.2 Global Virus-like Particle Revenue Market Share by Manufacturers (2019-2024)
3.3 Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Virus-like Particle Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Virus-like Particle Sales Sites, Area Served, Product Type
3.6 Virus-like Particle Market Competitive Situation and Trends
3.6.1 Virus-like Particle Market Concentration Rate
3.6.2 Global 5 and 10 Largest Virus-like Particle Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Virus-like Particle Industry Chain Analysis
4.1 Virus-like Particle Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Virus-like Particle Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Virus-like Particle Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Virus-like Particle Sales Market Share by Type (2019-2024)
6.3 Global Virus-like Particle Market Size Market Share by Type (2019-2024)
6.4 Global Virus-like Particle Price by Type (2019-2024)
7 Virus-like Particle Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Virus-like Particle Market Sales by Application (2019-2024)
7.3 Global Virus-like Particle Market Size (M USD) by Application (2019-2024)
7.4 Global Virus-like Particle Sales Growth Rate by Application (2019-2024)
8 Virus-like Particle Market Segmentation by Region
8.1 Global Virus-like Particle Sales by Region
8.1.1 Global Virus-like Particle Sales by Region
8.1.2 Global Virus-like Particle Sales Market Share by Region
8.2 North America
8.2.1 North America Virus-like Particle Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Virus-like Particle Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Virus-like Particle Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Virus-like Particle Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Virus-like Particle Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 The Native Antigen Company
9.1.1 The Native Antigen Company Virus-like Particle Basic Information
9.1.2 The Native Antigen Company Virus-like Particle Product Overview
9.1.3 The Native Antigen Company Virus-like Particle Product Market Performance
9.1.4 The Native Antigen Company Business Overview
9.1.5 The Native Antigen Company Virus-like Particle SWOT Analysis
9.1.6 The Native Antigen Company Recent Developments
9.2 Creative BioStructure
9.2.1 Creative BioStructure Virus-like Particle Basic Information
9.2.2 Creative BioStructure Virus-like Particle Product Overview
9.2.3 Creative BioStructure Virus-like Particle Product Market Performance
9.2.4 Creative BioStructure Business Overview
9.2.5 Creative BioStructure Virus-like Particle SWOT Analysis
9.2.6 Creative BioStructure Recent Developments
9.3 Creative Biolabs
9.3.1 Creative Biolabs Virus-like Particle Basic Information
9.3.2 Creative Biolabs Virus-like Particle Product Overview
9.3.3 Creative Biolabs Virus-like Particle Product Market Performance
9.3.4 Creative Biolabs Virus-like Particle SWOT Analysis
9.3.5 Creative Biolabs Business Overview
9.3.6 Creative Biolabs Recent Developments
9.4 Leadgene Biomedical
9.4.1 Leadgene Biomedical Virus-like Particle Basic Information
9.4.2 Leadgene Biomedical Virus-like Particle Product Overview
9.4.3 Leadgene Biomedical Virus-like Particle Product Market Performance
9.4.4 Leadgene Biomedical Business Overview
9.4.5 Leadgene Biomedical Recent Developments
9.5 Abcam
9.5.1 Abcam Virus-like Particle Basic Information
9.5.2 Abcam Virus-like Particle Product Overview
9.5.3 Abcam Virus-like Particle Product Market Performance
9.5.4 Abcam Business Overview
9.5.5 Abcam Recent Developments
9.6 ACROBiosystems
9.6.1 ACROBiosystems Virus-like Particle Basic Information
9.6.2 ACROBiosystems Virus-like Particle Product Overview
9.6.3 ACROBiosystems Virus-like Particle Product Market Performance
9.6.4 ACROBiosystems Business Overview
9.6.5 ACROBiosystems Recent Developments
9.7 Gentarget
9.7.1 Gentarget Virus-like Particle Basic Information
9.7.2 Gentarget Virus-like Particle Product Overview
9.7.3 Gentarget Virus-like Particle Product Market Performance
9.7.4 Gentarget Business Overview
9.7.5 Gentarget Recent Developments
9.8 VectorBuilder
9.8.1 VectorBuilder Virus-like Particle Basic Information
9.8.2 VectorBuilder Virus-like Particle Product Overview
9.8.3 VectorBuilder Virus-like Particle Product Market Performance
9.8.4 VectorBuilder Business Overview
9.8.5 VectorBuilder Recent Developments
10 Virus-like Particle Market Forecast by Region
10.1 Global Virus-like Particle Market Size Forecast
10.2 Global Virus-like Particle Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Virus-like Particle Market Size Forecast by Country
10.2.3 Asia Pacific Virus-like Particle Market Size Forecast by Region
10.2.4 South America Virus-like Particle Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Virus-like Particle by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Virus-like Particle Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Virus-like Particle by Type (2025-2030)
11.1.2 Global Virus-like Particle Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Virus-like Particle by Type (2025-2030)
11.2 Global Virus-like Particle Market Forecast by Application (2025-2030)
11.2.1 Global Virus-like Particle Sales (K Units) Forecast by Application
11.2.2 Global Virus-like Particle Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings